Company Locales
These are the locales owned and operated by this company. Please don't forget that when a locale runs out of money, the people employed there won't get their salary and they'll quit their jobs and perhaps even trash the locale. Also, if the condition falls to the bottom the locale can collapse at any given moment.
Select View
| Locales |
Cash |
Quality |
Condition |
| 5* restaurant SEA |
8690806
869,080.60 M$
|
50
|
100
|
| Aguccim Records LATIN |
122917438
12,291,743.80 M$
|
50
|
100
|
| Aguccim Records POP |
120627397
12,062,739.70 M$
|
50
|
100
|
| Counterfeit CDs NAS (I) |
19211700
1,921,170.00 M$
|
50
|
100
|
| Counterfeit CDs NAS (II) |
50532670
5,053,267.00 M$
|
50
|
100
|
| Counterfeit CDs NAS (III) |
32907286
3,290,728.60 M$
|
50
|
100
|
| Counterfeit CDs NAS (IV) |
33816608
3,381,660.80 M$
|
50
|
100
|
| HQ North -South America |
2633862
263,386.20 M$
|
50
|
100
|
| Second Lead Syndrome AMS |
39884460
3,988,446.00 M$
|
50
|
100
|
| Second Lead Syndrome ANK |
35662570
3,566,257.00 M$
|
50
|
100
|
| Second Lead Syndrome ANT |
31365545
3,136,554.50 M$
|
50
|
100
|
| Second Lead Syndrome BAK |
29203582
2,920,358.20 M$
|
50
|
100
|
| Second Lead Syndrome BAR |
37411008
3,741,100.80 M$
|
50
|
100
|
| Second Lead Syndrome BEL |
29520343
2,952,034.30 M$
|
50
|
100
|
| Second Lead Syndrome BER |
20235270
2,023,527.00 M$
|
50
|
100
|
| Second Lead Syndrome BRU |
19322132
1,932,213.20 M$
|
50
|
100
|
| Second Lead Syndrome BUC |
29351179
2,935,117.90 M$
|
50
|
100
|
| Second Lead Syndrome BUD |
30490773
3,049,077.30 M$
|
50
|
100
|
| Second Lead Syndrome BUE |
31337111
3,133,711.10 M$
|
50
|
100
|
| Second Lead Syndrome CHI |
29308569
2,930,856.90 M$
|
50
|
100
|
| Second Lead Syndrome COP |
19571569
1,957,156.90 M$
|
50
|
100
|
| Second Lead Syndrome DUB |
30610406
3,061,040.60 M$
|
50
|
100
|
| Second Lead Syndrome GLA |
20050379
2,005,037.90 M$
|
50
|
100
|
| Second Lead Syndrome HEL |
19754584
1,975,458.40 M$
|
50
|
100
|
| Second Lead Syndrome IST |
31480318
3,148,031.80 M$
|
50
|
100
|
| Second Lead Syndrome IZM |
35393998
3,539,399.80 M$
|
50
|
100
|
| Second Lead Syndrome JAK |
28610844
2,861,084.40 M$
|
50
|
100
|
| Second Lead Syndrome JOH |
34360230
3,436,023.00 M$
|
50
|
100
|
| Second Lead Syndrome KYIV |
19618739
1,961,873.90 M$
|
50
|
100
|
| Second Lead Syndrome L.A. |
33127216
3,312,721.60 M$
|
50
|
100
|
| Second Lead Syndrome LON |
34942908
3,494,290.80 M$
|
50
|
100
|
| Second Lead Syndrome MAD |
30102647
3,010,264.70 M$
|
50
|
100
|
| Second Lead Syndrome MAN |
31902421
3,190,242.10 M$
|
50
|
100
|
| Second Lead Syndrome MEL |
31244915
3,124,491.50 M$
|
50
|
100
|
| Second Lead Syndrome MEX |
29623156
2,962,315.60 M$
|
50
|
100
|
| Second Lead Syndrome MIL |
22440387
2,244,038.70 M$
|
50
|
100
|
| Second Lead Syndrome MON |
31052501
3,105,250.10 M$
|
50
|
100
|
| Second Lead Syndrome MOS |
21480358
2,148,035.80 M$
|
50
|
100
|
| Second Lead Syndrome NAS |
33466749
3,346,674.90 M$
|
50
|
100
|
| Second Lead Syndrome NYC |
29922220
2,992,222.00 M$
|
50
|
100
|
| Second Lead Syndrome PAR |
38622469
3,862,246.90 M$
|
50
|
100
|
| Second Lead Syndrome POR |
34374169
3,437,416.90 M$
|
50
|
100
|
| Second Lead Syndrome RIO |
32118251
3,211,825.10 M$
|
50
|
100
|
| Second Lead Syndrome ROM |
29295202
2,929,520.20 M$
|
50
|
100
|
| Second Lead Syndrome SAO |
35143574
3,514,357.40 M$
|
50
|
100
|
| Second Lead Syndrome SAR |
32576420
3,257,642.00 M$
|
50
|
100
|
| Second Lead Syndrome SEA |
31184841
3,118,484.10 M$
|
50
|
100
|
| Second Lead Syndrome SHA |
31192694
3,119,269.40 M$
|
50
|
100
|
| Second Lead Syndrome SIN |
29814422
2,981,442.20 M$
|
50
|
100
|
| Second Lead Syndrome SOF |
24551049
2,455,104.90 M$
|
50
|
100
|
| Second Lead Syndrome STO |
32327090
3,232,709.00 M$
|
50
|
100
|
| Second Lead Syndrome TAL |
22593334
2,259,333.40 M$
|
50
|
100
|
| Second Lead Syndrome TOK |
29538696
2,953,869.60 M$
|
50
|
100
|
| Second Lead Syndrome TOR |
30435037
3,043,503.70 M$
|
50
|
100
|
| Second Lead Syndrome TRO |
20260549
2,026,054.90 M$
|
50
|
100
|
| Second Lead Syndrome VIL |
25015369
2,501,536.90 M$
|
50
|
100
|
| Second Lead Syndrome WAR |
22994205
2,299,420.50 M$
|
50
|
100
|